Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Supernus Pharm (SUPN)

Supernus Pharm (SUPN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Supernus Pharm 1550 E GUDE DR ROCKVILLE MD 20850 USA

P: 301-838-2500

Description:

Supernus Pharmaceuticals Inc. is a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system diseases. It is developing several product candidates in neurology and psychiatry to address opportunities in epilepsy and attention deficit hyperactivity disorder. Supernus Pharmaceuticals Inc. is based in Rockville, Maryland.

Key Statistics

Overview:

Market Capitalization, $K 1,477,990
Shares Outstanding, K 53,146
Annual Sales, $ 520,400 K
Annual Net Income, $ 126,950 K
Last Quarter Sales, $ 141,330 K
Last Quarter Net Income, $ 23,730 K
60-Month Beta 1.22
% of Insider Shareholders 7.99%
Float, K 48,900
% Float 92.01%

Growth:

1-Year Return 37.67%
3-Year Return -44.77%
5-Year Return 12.45%
5-Year Revenue Growth 260.31%
5-Year Earnings Growth 661.29%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.43 on 08/04/21
Next Earnings Date 11/02/21
Earnings Per Share ttm 1.85
EPS Growth vs. Prev Qtr 290.91%
EPS Growth vs. Prev Year -33.85%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

SUPN Ratios

Ratio
Price/Earnings ttm 14.56
Price/Earnings forward 25.08
Price/Earnings to Growth N/A
Return-on-Equity % 13.39%
Return-on-Assets % 6.58%
Profit Margin % 24.39
Net Margin % N/A
Debt/Equity 0.49
Price/Sales 2.75
Price/Cash Flow 9.11
Price/Book 1.85
Book Value/Share 14.82
Interest Coverage 8.10
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar